PubMed · 11786304
Serotonergic targets in depression.
Abstract
Serotonin reuptake inhibitors have proved to be a very effective treatment for depression and have strengthened the hypothesis that impaired 5-hydroxytryptamine (5-HT) neurotransmission may contribute to the underlying cause of depressive disorders. Extensive research has been carried out to investigate other 5-HT targets associated with the disease and studies involving combination treatments with selective serotonin reuptake inhibitors and 5-HT(1A) receptor ligands are currently being carried out in the clinic. Whether other 5-HT receptor subtypes are involved in the aetiology of depression remains to be seen.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Derek N Middlemiss, Gary W Price, Jeannette M Watson. 2002. Serotonergic targets in depression.. https://doi.org/10.1016/s1471-4892(01)00116-3
Cite the original work for its findings. Save a collection to share your selection of sources.